Literature DB >> 28942765

Mask Refills as a Measure of PAP Adherence.

Matthew T Scharf1,2,3, Brendan T Keenan4, Allan I Pack1,4, Samuel T Kuna1,2,4.   

Abstract

STUDY
OBJECTIVES: Positive airway pressure (PAP) adherence data are a routine aspect of clinical care for obstructive sleep apnea (OSA), but not uniformly available. We hypothesized that mask refills are a measure of PAP adherence.
METHODS: We measured PAP use over the first 90 days of treatment in 123 patients with OSA. The number and timing of mask refills was assessed over 18 months. Demographic and medical information was obtained from the electronic medical record.
RESULTS: Average PAP use in the first week of more than 4 h/d was a predictor of adherence over the first 90 days (P < .0001). PAP use over 90 days was greater in datacard-derived data dependent on patients presenting a datacard to the clinic compared to modem-derived data (P = .0006). A mask refill within the first 30 days of treatment was associated with a 1.3 h/d lower PAP usage in the first 90 days (P = .0044). Conversely, the number of mask refills between 30 days and 18 months was associated with higher PAP adherence during the first 90 days, with an additional 0.61 h/d of use for each additional refill (P = .0015).
CONCLUSIONS: In a retrospective cohort of veterans with OSA, first week PAP use was a strong predictor of 90-day use. Use of autonomously transmitted modem data avoided potential selection bias in adherence estimates. Mask refills in the first month were associated with less 90-day PAP use, whereas more mask refills after 30 days were associated with greater PAP use.
© 2017 American Academy of Sleep Medicine

Entities:  

Keywords:  OSA; PAP; adherence; datacard; mask refills; modem

Mesh:

Year:  2017        PMID: 28942765      PMCID: PMC5656483          DOI: 10.5664/jcsm.6810

Source DB:  PubMed          Journal:  J Clin Sleep Med        ISSN: 1550-9389            Impact factor:   4.062


  21 in total

1.  Race and residential socioeconomics as predictors of CPAP adherence.

Authors:  Martha E Billings; Dennis Auckley; Ruth Benca; Nancy Foldvary-Schaefer; Conrad Iber; Susan Redline; Carol L Rosen; Phyllis Zee; Vishesh K Kapur
Journal:  Sleep       Date:  2011-12-01       Impact factor: 5.849

2.  Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study.

Authors:  Jose M Marin; Santiago J Carrizo; Eugenio Vicente; Alvar G N Agusti
Journal:  Lancet       Date:  2005 Mar 19-25       Impact factor: 79.321

3.  Long-term compliance with CPAP therapy in obstructive sleep apnea patients and in snorers.

Authors:  J Krieger; D Kurtz; C Petiau; E Sforza; D Trautmann
Journal:  Sleep       Date:  1996-11       Impact factor: 5.849

4.  Noninferiority of functional outcome in ambulatory management of obstructive sleep apnea.

Authors:  Samuel T Kuna; Indira Gurubhagavatula; Greg Maislin; Sakhena Hin; Kathryn C Hartwig; Sue McCloskey; Robert Hachadoorian; Sharon Hurley; Rajesh Gupta; Bethany Staley; Charles W Atwood
Journal:  Am J Respir Crit Care Med       Date:  2011-01-21       Impact factor: 21.405

5.  The impact of posttraumatic stress disorder on CPAP adherence in patients with obstructive sleep apnea.

Authors:  Jacob F Collen; Christopher J Lettieri; Monica Hoffman
Journal:  J Clin Sleep Med       Date:  2012-12-15       Impact factor: 4.062

6.  Predictors of long-term adherence to continuous positive airway pressure therapy in patients with obstructive sleep apnea and cardiovascular disease in the SAVE study.

Authors:  Ching Li Chai-Coetzer; Yuan-Ming Luo; Nick A Antic; Xi-Long Zhang; Bao-Yuan Chen; Quan-Ying He; Emma Heeley; Shao-Guang Huang; Craig Anderson; Nan-Shan Zhong; R Doug McEvoy
Journal:  Sleep       Date:  2013-12-01       Impact factor: 5.849

7.  Obstructive sleep apnea and the recurrence of atrial fibrillation.

Authors:  Ravi Kanagala; Narayana S Murali; Paul A Friedman; Naser M Ammash; Bernard J Gersh; Karla V Ballman; Abu S M Shamsuzzaman; Virend K Somers
Journal:  Circulation       Date:  2003-05-12       Impact factor: 29.690

8.  Long-term adherence to nasal continuous positive airway pressure therapy by hypertensive patients with preexisting sleep apnea.

Authors:  Taiji Furukawa; Masaaki Suzuki; Mina Ochiai; Hideyuki Kawashima; Naoyuki Yokoyama; Takaaki Isshiki
Journal:  J Cardiol       Date:  2013-10-20       Impact factor: 3.159

9.  Early CPAP use identifies subsequent adherence to CPAP therapy.

Authors:  Rohit Budhiraja; Sairam Parthasarathy; Christopher L Drake; Thomas Roth; Imran Sharief; Pooja Budhiraja; Victoria Saunders; David W Hudgel
Journal:  Sleep       Date:  2007-03       Impact factor: 5.849

10.  Neighborhood of residence is associated with daily adherence to CPAP therapy.

Authors:  Alec B Platt; Samuel H Field; David A Asch; Zhen Chen; Nirav P Patel; Rajesh Gupta; Dominic F Roche; Indira Gurubhagavatula; Jason D Christie; Samuel T Kuna
Journal:  Sleep       Date:  2009-06       Impact factor: 5.849

View more
  4 in total

1.  CPAP adherence reduces cardiovascular risk among older adults with obstructive sleep apnea.

Authors:  Emerson M Wickwire; M Doyinsola Bailey; Virend K Somers; Mukta C Srivastava; Steven M Scharf; Abree M Johnson; Jennifer S Albrecht
Journal:  Sleep Breath       Date:  2020-11-03       Impact factor: 2.816

2.  Sex differences in Epworth Sleepiness Scale normalization with continuous positive airway pressure.

Authors:  Matthew T Scharf; Peng Zhang; Nathan A Walker; Mariam Mirza; Aesha M Jobanputra; R Nisha Aurora; Jag Sunderram; Shou-En Lu
Journal:  J Clin Sleep Med       Date:  2022-09-01       Impact factor: 4.324

3.  Evaluation of CPAP mask performance during 3 years of mask usage: time for reconsideration of renewal policies?

Authors:  Atte Laaka; Maria Hollmén; Adel Bachour
Journal:  BMJ Open Respir Res       Date:  2021-11

4.  CPAP adherence is associated with reduced risk for stroke among older adult Medicare beneficiaries with obstructive sleep apnea.

Authors:  Emerson M Wickwire; M Doyinsola Bailey; Virend K Somers; Mukta C Srivastava; Steven M Scharf; Abree M Johnson; Jennifer S Albrecht
Journal:  J Clin Sleep Med       Date:  2021-06-01       Impact factor: 4.324

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.